Description
Jemperli is a cancer medicine for treating certain types of endometrial cancer (cancer of the womb) that are advanced or have come back. It is used:
- together with carboplatin and paclitaxel (other cancer medicines, also called chemotherapy) in adults whose cancer is suitable for systemic therapy (treatment that affects the whole body);
- on its own in adults whose cancer has got worse despite treatment involving a platinum-based cancer medicine.
Jemperli is for endometrial cancer where the cancer cells have genetic abnormalities (called mismatch repair deficiency and high microsatellite instability) which prevent the cells from correcting mistakes that occur during cell division.
Reviews
There are no reviews yet.